Connect with us

Technology

Visible Validation in Lab tests demonstrate no direct relationship between module size and deformations

Published

on

NINGBO, China, March 20, 2023 /PRNewswire/ — Innovations in technology continue to be the key driver of the rapid growth of the solar industry, and now, the industry has entered a new era in which large-size modules are becoming increasingly dominant. An increasingly extensive lineup of application solutions and technological advances have led to a continued decline in the levelized cost of energy (LCOE), making the large-size modules the preferred choice of customers, with modules made of 210mm and 182mm solar cells serving as prime examples. According to data from the China Photovoltaic Industry Association, aforementioned large-size modules together have taken an 82.8% share of the PV sector in 2022 and the ratio is expected to reach 93.2% in 2023. Solar power stations can cut costs by using large-size modules that significantly reduce balance-of-system (BOS) costs and the LCOE. As a result, the speed at which the high power modules are taking over the market is becoming an inevitable trend.

Some rumors have been floating around the market lately implying that the modules of size 2384x1303mm made of 132pcs half-cut 210mm solar cells (refer as 210-66 cells module), given that they are larger than the modules of size 2278x1134mm made of 144pcs half-cut 182mm solar cells (refer as 182-72 cells module), are 40% to 60% more likely to deform under the same load condition, increasing the risk of micro-cracks while reducing the level of reliability.

Is this the truth?

To verify the validity of the statement, Risen Energy conducted a test at a China National Accreditation Service for Conformity Assessment-certified lab, during which a Titan dual-glass 210-66 cells module with aluminum frame was compared with a dual-glass 182-72 cells module with aluminum frame in terms of deformation by using the same beamless installation with outer four holes mounting under identical load and test conditions.

 

The results of the test show that compared with the 182-72 cells module, the 210-66 cells module demonstrated 1% less deformation on the short side and 4% more deformation at the center of the glass, with no micro-cracks following the Electroluminescence (EL) testing, when installed in a beamless manner with outer four mounting holes under a load of 3600Pa (front side).

 

At the same time, Risen Energy conducted a second test during which a Titan dual-glass 210-66 cells module with steel frame was compared with a dual-glass 182-72 cells module with aluminum frame in terms of deformation by using the same beamless installation with outer four mounting holes under the identical load and test conditions.

The results of the test show that compared with the 182-72 cells module, the 210-66 cells module with a steel frame demonstrated 53% less deformation on the short side and 15% less deformation at the center of the glass, with no micro-cracks following the EL testing, when installed in a beamless manner with outer four holes under a load of 3600Pa (front side).

Proven facts fear no rumours

The results of the two tests show that there is no particular difference in deformation between the 210-66 cells module and the 182-72 cells module when using an aluminum frame under the same load conditions; the 210-66 cells module had significantly fewer deformation when installed with a steel frame.

It is generally true that the larger and longer an object, the more likely it is to deform, nevertheless, this can be fully controlled through proper design. For example, a piece of steel will sink when placed in water, but it can float if it is designed to be a boat. PV modules are all created under a rigorous development process during which the materials and design cannot be finalized until stringent and detailed design validation and testing are completed. This approach was strictly followed at every stage of the design and development of Risen Energy’s 210 series. With shipments exceeding 25GW since its launch in 2019, the series has been widely used in a variety of application scenarios globally, including large-scale power plants, industrial and commercial rooftops as well as residential rooftops while, at the same time, receiving kudos from both domestic and overseas customers for its outstanding performance.

Yield strength (YS) is the parameter that determines the maximum stress that a material can withstand. All deformations caused by pressures that do not exceed YS are elastic deformations, also known as recoverable deformations. Such deformations do not damage the material’s structure as only pressures exceeding the YS can cause destructive plastic deformations. It is normal for modules to experience different degrees of deformation under different loads, but, to assess the load capacity and reliability of a module by simply looking at its deformations is considered neither a rigorous nor a scientifically valid approach. In brief, it is simply wrong to say that the larger a module is, the more deformations it must has.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/visible-validation-in-lab-tests-demonstrate-no-direct-relationship-between-module-size-and-deformations-301776722.html

SOURCE Risen Energy Co., Ltd

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Charles IT Ranked 98th on Channel Futures 2024 MSP 501–Tech Industry’s Most Prestigious List of Managed Service Providers Worldwide

Published

on

By

Charles IT has been named as one of the world’s top-performing managed service providers in the prestigious 2024 Channel Futures MSP 501 rankings. The Channel Futures MSP 501 list, a technology industry benchmark, ranks companies based on their growth, profitability, and innovation.

Annual Channel Futures MSP 501 Identifies Best of the Best in the Managed Services Industry

MIDDLETOWN, Conn., June 23, 2024 /PRNewswire-PRWeb/ — Charles IT has been named as one of the world’s top-performing managed service providers in the prestigious 2024 Channel Futures MSP 501 rankings. The Channel Futures MSP 501 list, a technology industry benchmark, ranks companies based on their growth, profitability, and innovation.

“Our goal is to always ensure that all the businesses we work with are protected with security services, and that those security services are customized to their business needs…”

For the past 17 years, managed service providers around the globe have submitted applications for inclusion on this prestigious and definitive listing. It is a milestone achievement for any managed services organization to be included. The Channel Futures MSP 501 survey uses a quantitative methodology to rank companies based on their annual revenue, profitability measured by EBITDA, and recurring revenue. The methodology has been developed by a Who’s-Who in the managed services industry.

MSPs that qualify for the list must also pass a rigorous review conducted by the Channel Futures research team and editors. Channel Futures ranks applicants using a unique methodology that weighs financial performance according to long-term health and viability, commitment to recurring revenue, and operational efficiency.

Channel Futures is pleased to name Charles IT to the 2024 MSP 501.

“Our goal is to always ensure that all the businesses we work with are protected with security services, and that those security services are customized to their business needs,” said Foster Charles, Founder & CEO, Charles IT. “I’m often meeting with business leaders to discuss their IT and cybersecurity challenges and providing as much guidance on navigating their IT environment as I can.”

This year’s list is among the most competitive in the survey’s history. Winners will be recognized on the Channel Futures website and honored during a special ceremony at MSP Summit, Sept 16-19, 2024 in Atlanta, GA.

The MSP 501 represents the best in the technology services industry, delivering outstanding vendor and platform-neutral advice and value to small, midsized, and enterprise customers. This year, the MSP 501 generated aggregate revenue of nearly $25 billion with an average growth or recurring revenue of 19%. These are truly the best of the best. Many of their services and technology offerings focus on customer needs in the areas of AI, cloud, security, collaboration, networking, help desk, and remote monitoring and management.

The Channel Futures MSP 501 keeps its global customers safe, connected, and efficient.

“The 2024 Channel Futures MSP 501 winners survived a challenging market and emerged as the highest performing and most innovative IT providers in the industry today,” said Dave Raffo, MSP editor and MSP 501 project manager. “The most impressive thing about the MSP 501 winners is they deliver for their customers every day. These are the most innovative, driven, and successful MSPs in a fiercely competitive industry.”

“For a managed service provider to attain a spot on the Channel Futures MSP 501 everything must be operating at peak performance. This list represents the most productive, profitable, fastest-growing, organizations in the technology industry focused on driving their customers to new heights,” said Bob DeMarzo, VP Content, Informa Channels.

“These are the best of the best in the managed services industry as defined by Channel Futures’ extensive research. The MSP 501 companies are the most sought after by peers who want to understand today’s best practices and by technology suppliers who want to partner with these organizations,” DeMarzo stated. “At their core, these are vendor and platform neutral partners focused on doing what is right for their customers.”

The Channel Futures media organization, owned and operated by Informa, is the only channel-centric events, media, and research company to provide such insight into the managed services market.

The data collected by the annual MSP 501 helps every company on the list, and every provider with a managed services practice to benchmark their performance and uncover new ways to grow.

Background

The 2024 MSP 501 list is based on confidential data collected and analyzed by the Channel Futures research and editorial teams. Data was collected online from February to May, 2024. The MSP 501 list recognizes top managed service providers based on metrics including recurring revenue, profit margin and other factors.

About Charles IT

As the Northeast’s Compliance Expert, Charles IT is known for providing friendly and no-nonsense IT service and support. With a focus on helping companies in highly regulated industries with their IT needs, Charles IT emphasizes the importance of building ‘real relationships’ that lead to tangible results. Charles IT takes pride in being readily available for clients, always equipped with a solution and a smile. Charles IT’s commitment to service and results has earned the company a place as a trusted member of client teams, creating raving fans who value Charles IT’s dedication to exceptional service.

About Channel Futures

Channel Futures is a media and events destination for the information technology and communications industry. We provide information, perspective, and connection for the entire channel ecosystem, including solution providers (SPs), managed service providers (MSPs), managed security service providers (MSSPs), cloud service providers (CSPs), value-added resellers (VARs) and distributors, technology solutions brokerages, subagent and agents, as well as leading technology vendor partners and communication providers.

Channel Futures is where the world meets the channel; we are leading Channel Partners forward. Our properties include awards programs such as the Channel Futures MSP 501, a list of the most influential and fastest-growing providers of managed services in the technology industry; Channel Partners events, which delivers unparalleled in-person events including Channel Partners Conference & Expo and MSP Summit. More information is available at channelfutures.com.

Channel Futures is part of Informa Tech, a leading provider of market insight and market access to the global business technology community. Through in-depth expertise and an engaged audience community, Informa Tech helps business professionals make better technology decisions, and marketers reach the world’s most powerful tech buyers and influencers. Across its portfolio of over 100+ trusted brands, Informa Tech has over 1000 industry experts, including over 400 research analysts and consultants in the global research group Omdia, and a monthly audience reach of over 125 million. Informa Tech is a division of FTSE 100 company Informa plc.

Media Contacts

Betta Greenberg

Marketing Manager, Charles IT

bettag@CharlesIT.com

Dave Raffo

MSP News Editor, Channel Futures

david.raffo@informa.com

Katie Egley

Senior Marketing Manager

msp501@informa.com

Media Contact

Betta Greenberg, Charles IT, 1 8603449628, bettag@charlesit.com, charlesit.com

View original content:https://www.prweb.com/releases/charles-it-ranked-98th-on-channel-futures-2024-msp-501tech-industrys-most-prestigious-list-of-managed-service-providers-worldwide-302179470.html

SOURCE Charles IT

Continue Reading

Technology

Science and Technology Daily: Global Talents Enjoy the Honor of China

Published

on

By

BEIJING, June 23, 2024 /PRNewswire/ — It’s a tremendous honor to receive the China International Science and Technology Cooperation Award. We pay high tribute to those honorees who have made important contributions to scientific and technological advancements. Let’s look forward to seeing who will be awarded this honor this year.

View original content to download multimedia:https://www.prnewswire.com/news-releases/science-and-technology-daily-global-talents-enjoy-the-honor-of-china-302179675.html

SOURCE Science and Technology Daily

Continue Reading

Technology

Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa

Published

on

By

SINGAPORE, June 23, 2024 /PRNewswire/ — Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)’ solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion follows the initial January 2023 distribution rights partnership with Caris for the same services in Southeast Asia (SEA). Juniper is now poised to offer Caris’ advanced solid tumour molecular profiling services across a broader region, enhancing patient access to personalised treatment options.

Caris’ best-in-class molecular profiling, combined with proprietary artificial intelligence, provides more precise and individualized cancer treatments. This profiling approach assesses DNA, RNA, and proteins, revealing a molecular blueprint that identifies treatment options specific to each patient’s cancer. Caris has developed the world’s largest and most informative platform for cancer analysis, featuring the most advanced tumour profiling available, including Whole Exome and Whole Transcriptome Sequencing across over 23,000 genes. By analysing biomarkers found in tumours, Caris helps healthcare providers make informed choices for personalised care.

Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper’s collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced therapies is limited.

Raman Singh, Founder and Chief Executive Officer (CEO) of Juniper Biologics, spoke on the successful acquisition: “Caris molecular profiling bridges the gap between tumour biology and cancer treatments, guiding precision medicine through personalised treatment selection for physicians and their patients. Our exclusive partnership with Caris Life Sciences to distribute this service in the Middle East and Africa will significantly empower healthcare professionals to make informed decisions for their patients. This service enables oncologists to recommend highly personalised treatments that specifically target a patient’s cancer, thereby improving and expanding their care options. This targeted approach offers patients, particularly those with rare or aggressive cancers, an improved quality of life.”

“Caris is pleased to expand the distribution of our molecular profiling services in the Middle East and Africa through our partnership with Juniper Biologics,” said Caris President David Spetzler, MS, PhD, MBA. “This collaboration aligns with Caris’ goal of enabling clinicians worldwide to make the best individualised treatment choices for their patients and ultimately helping to improve patient outcomes.”

This partnership marks a significant milestone in expanding access to personalised medicine and advanced cancer treatment technologies in the Middle East and Africa.

About Juniper Biologics

Backed by The Sylvan Group, Juniper Biologics is a science-led healthcare company focused on delivering novel therapies to improve the health and quality of life of patients, by building a growing presence in Oncology and Oncology Supportive Care, Rare/Orphan Diseases and Gene Therapy. It was founded on a vision to provide treatments for unmet medical needs focused on specialist therapy areas in which it can make the most difference. Through bold and transformative science, Juniper Biologics is committed to creating possibilities that have the potential to become the next generation of life-changing medicines for patient communities in China, Japan, Asia, Australia, New Zealand, Middle East, and Africa.

Website: https://www.juniperbiologics.com/

LinkedIn: https://www.linkedin.com/company/juniper-biologics

About Caris Life Sciences
Caris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyse and unravel the molecular complexity of disease. This convergence of sequencing power, big data, and AI technologies provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection, and drug development.

Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia, and other international markets. To learn more, please visit CarisLifeSciences.com.

 

View original content:https://www.prnewswire.co.uk/news-releases/juniper-biologics-expands-distribution-rights-for-caris-life-sciences-molecular-profiling-in-the-middle-east-and-africa-302179643.html

Continue Reading

Trending